2010
DOI: 10.3923/javaa.2010.1055.1067
|View full text |Cite
|
Sign up to set email alerts
|

Bone Grafting and Bone Graft Substitutes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
32
0
2

Year Published

2012
2012
2021
2021

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 31 publications
(38 citation statements)
references
References 0 publications
0
32
0
2
Order By: Relevance
“…Moreover, it decreased MPO and ALP release by neutrophils in all measurements. The obtained results indicated that PR-39 inhibited secretory activity of neutrophils except for elastase release, which is essential in the first phase of injury (Kaveh et al, 2010).…”
Section: Discussionmentioning
confidence: 79%
See 1 more Smart Citation
“…Moreover, it decreased MPO and ALP release by neutrophils in all measurements. The obtained results indicated that PR-39 inhibited secretory activity of neutrophils except for elastase release, which is essential in the first phase of injury (Kaveh et al, 2010).…”
Section: Discussionmentioning
confidence: 79%
“…Similarly, in the first phase of bone graft incorporation during the first 18 h, the arrival of chemotactic factors and an accumulation of neutrophils as inflammatory cells are observed. This process is connected with elastase release and generation of inflammatory factors such as collagenous and fibronectin peptides (Kaveh et al, 2010).…”
Section: Introductionmentioning
confidence: 99%
“…In the first phase of bone graft incorporation, during the first 18 h a chemotactic factor arrival and an accumulation of neutrophils as inflammatory cells are observed. This process is connected with elastase release producing chemotactic factors such as collagenous and fibronectin peptides (Kaveh et al, 2010). Immediately following injury, neutrophils migrate toward the implant site and this recruitment is triggered by chemoattractants.…”
Section: Discussionmentioning
confidence: 99%
“…При всех успехах трансплантации кости нельзя не отметить, что далеко не всегда оперативное вмешательство, необходимое для взятия аутотрансплантата, бывает оправдано, так как при этом вызывается дополнительная травма донорского участка ор-ганизма, а основным недостатком аллотрансплантации, до на-стоящего времени считавшейся более перспективной, является проблема иммунной совместимости материала донора и реципи-ента [3][4][5][6][7][8][9]. В последние годы значительное внимание уделяется созда-нию керамических материалов медицинского назначения, пред-назначенных для использования при реконструкции дефектов костных тканей, образующихся в результате патологических из-менений в организме, обширных хирургических вмешательств или травм.…”
unclassified